BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gu L, Wang M, Cui X, Mo J, Yuan L, Mao F, Zhang K, Ng DM, Chen P, Wang D. Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection. BMC Surg 2020;20:219. [PMID: 33008382 DOI: 10.1186/s12893-020-00884-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ding P, Yang P, Sun C, Tian Y, Guo H, Liu Y, Li Y, Zhao Q. Predictive Effect of Systemic Immune-Inflammation Index Combined With Prognostic Nutrition Index Score on Efficacy and Prognosis of Neoadjuvant Intraperitoneal and Systemic Paclitaxel Combined With Apatinib Conversion Therapy in Gastric Cancer Patients With Positive Peritoneal Lavage Cytology: A Prospective Study. Front Oncol 2022;11:791912. [DOI: 10.3389/fonc.2021.791912] [Reference Citation Analysis]
2 Pikuła A, Skórzewska M, Pelc Z, Mlak R, Gęca K, Sędłak K, Ciseł B, Kwietniewska M, Rawicz-pruszyński K, Polkowski WP. Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population. Cancers 2022;14:1997. [DOI: 10.3390/cancers14081997] [Reference Citation Analysis]
3 Pang H, Zhang W, Liang X, Zhang Z, Chen X, Zhao L, Liu K, Galiullin D, Yang K, Chen X, Hu J. Prognostic Score System Using Preoperative Inflammatory, Nutritional and Tumor Markers to Predict Prognosis for Gastric Cancer: A Two-Center Cohort Study. Adv Ther 2021;38:4917-34. [PMID: 34379305 DOI: 10.1007/s12325-021-01870-z] [Reference Citation Analysis]
4 Du S, Fang Z, Ye L, Sun H, Deng G, Wu W, Zeng F. Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy. Aging (Albany NY) 2021;13:17638-54. [PMID: 34245559 DOI: 10.18632/aging.203256] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 He Q, Li Y, Zhou X, Zhou W, Xia C, Zhang R, Zhang Z, Hu A, Peng S, Li J. The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs. J Int Med Res 2021;49:3000605211004021. [PMID: 33794676 DOI: 10.1177/03000605211004021] [Reference Citation Analysis]